Convalo Health International Corp. (Convalo) appointed David Costine to be non-executive Chairman of the Board of Directors and Edward Allera as a non-executive member of the Board of Directors. Both have extensive experience with companies operating in the US healthcare market.

Convalo will have a Board of Directors compromised of three independent directors. Michael Dalsin and Roger Greene will no longer have a role in corporate governance and will leave the board to focus exclusively on an advisory role, continuing to work with the senior management team on revenue expansion and profit growth. These changes will take effect March 1, 2016.

Mr. Costine was previously the managing general partner of Corporate Venture Partners LP, an institutional investment fund he founded. Mr. Allera is a shareholder and a former managing partner of the Washington, D.C. office for Buchanan Ingersoll &Rooney PC.